The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
from NYT > Health https://ift.tt/i1DhF8I
Subscribe to:
Post Comments (Atom)
-
Low density lipoprotein or simply known as cholesterol is dangerous to the heart and can lead to heart attack and stroke, but the good thing... -
Captive animals sometimes need a transfusion, but the typical approach to blood banking isn’t practical for zoos and aquariums. One veterina...
-
The health secretary said he would prioritize studies into environmental causes while harshly discounting other factors scientists say are l...
No comments:
Post a Comment